Strong Tower Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,093
Closed -$1.02M 93
2023
Q1
$1.02M Buy
25,093
+528
+2% +$22.8K 0.54% 46
2022
Q4
$1.26M Buy
24,565
+283
+1% +$13.6K 0.76% 33
2022
Q3
$1.06M Buy
24,282
+130
+0.5% +$6.32K 0.63% 40
2022
Q2
$1.27M Sell
24,152
-397
-2% -$20.2K 0.69% 32
2022
Q1
$1.27M Buy
24,549
+1,368
+6% +$71K 0.65% 42
2021
Q4
$1.37M Sell
23,181
-200
-0.9% -$9.91K 0.73% 31
2021
Q3
$969K Buy
+23,381
New +$1.04M 0.56% 46

Other funds holding PFE

Strong Tower Advisory Services's PFE Position: Q2 2023 in Review

Strong Tower Advisory Services sold out of Pfizer (PFE) in Q2 2023, closing a stake of 25,093 shares — an estimated $1.02M sold.

Strong Tower Advisory Services first reported a position in PFE in Q3 2021 and held it in 7 quarters. The position peaked at $1.37M in Q4 2021. 3,044 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Strong Tower Advisory Services reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Strong Tower Advisory Services sold 25,093 Pfizer shares in Q2 2023, an estimated $1.02M.
  • Strong Tower Advisory Services first reported a position in Pfizer in Q3 2021 and held it in 7 quarters.
  • Strong Tower Advisory Services's Pfizer position peaked at $1.37M in Q4 2021.
  • 3,044 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Strong Tower Advisory Services's 13F filing for Q2 2023, filed 14 Jul 2023.